INDOX is a partnership between Oxford University and twelve of the leading cancer centres in India:
- Birla Cancer Center, SMS Medical College Hospital, Jaipur
- Cachar Cancer Hospital & Research Centre, Silchar
- Cancer Institute (WIA), Chennai
- Christian Medical College, Vellore
- G. Kuppuswamy Naidu Memorial Hospital, Coimbatore
- Gujarat Cancer Research Institute, Ahmedabad
- Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi
- Kidwai Memorial Institute of Oncology, Bangalore
- Nizams Institute of Medical Sciences, Hyderabad
- Regional Cancer Centre, Trivandrum, Kerala
- Tata Medical Center, Kolkata
- Tata Memorial Hospital, Parel, Mumbai
The Birla Cancer Center is a part of the SMS Medical College Hospital, Jaipur and was first commissioned in August 1988 by the Chief Minister of Rajasthan as an out-patient center for cancer patients. Since then there have been many additions to the center and presently the center has two bone marrow transplant beds, one major and one minor surgical oncology operation rooms, an oncology ICU, 30 indoor beds along with all diagnostic modalities, such as colposcopy, mammograpy, endoscopy, diagnostic radiology and FNAC facilities. Last year (2010) 7608 new cases and 5886 follow up cases of cancer were seen at the center and more than 2300 cycles of chemotherapy were given there.
The Cachar Cancer Hospital and Research Centre (CCHRC), Silchar, Assam, serves an extremely underserved and economically impoverished community from the Cachar, Karimganj and Hailakandi districts in the Barak river valley in Assam state and from the states of Tripura, Manipur and Mizoram. It registers about 4000 new and 10000 follow-up patients annually. Nearly 75% of the patients work for daily wages, 60% of them earning an income of Rs. 3000 ($60) or less per month. CCHRC, one of the two comprehensive cancer centres in the north-east of India, was established through a community initiative in 1996. The hospital has facilities for chemotherapy, radiation and surgery. It also has divisions of pathology, diagnostic radiology, preventive oncology, pain and palliative care and epidemiology and tumour registry. There is also a molecular oncology lab, which was funded by a grant from The Department of Bio Technology (DBT), Government of India, and the hospital collaborates with the department of biotechnology, Assam University (a central university) in basic and applied research in cancer biology.
The Cancer Institute (WIA) is spread over 9 acres in Chennai, South India. The hospital houses 423 beds of which 297 are free. Over 1,25,000 patients are seen annually. They are drawn from all over India, parts of South and South East Asia. Over 66% of them are indigent and are treated free of charge. The hospital has state-of-the-art facilities for diagnosis, evaluation and treatment of cancer as well as rehabilitation.
Living its mission of providing state-of-the-art treatment to people with all types of cancers, the Institute is equipped with world class medical facilities. It houses a hospital, College of Oncological Sciences, an exclusive division for Preventive Oncology and a research center.
Christian Medical College and Hospital, Vellore, known as ‘CMC Vellore’ is a tertiary care hospital. The primary concern of the Christian Medical College, Vellore is to develop through education and training, compassionate, professionally excellent, ethically sound individuals who will go out as servant-leaders of health teams and healing communities. Their service may be in promotive, preventive, curative, rehabilitative or palliative aspects of health care in education or in research. CMC is committed to innovation and the adoption of new, appropriate, cost-effective, caring technology. In 2007-8, there were 115,000 outpatient visits and 6,400 inpatients. There are 200 beds and 140 nurses and staff. Medical Oncology services at CMC are provided by a multidisciplinary team. The team has Medical Oncologists, Physicians, Nurses, Clinical Pharmacists, and Pastoral Care professionals. This team provides care through all stages of cancer care including supportive care whenever needed. The department specializes in the treatment of cancers with chemotherapy and other biological therapies. Communication between the team members allows the staff to help patients and family members to understand the treatment and to finish the course of therapy. The staff encourages the patient and family members to become active participants in their care through patient education. The interdisciplinary management of malignant disease is the standard of care at the Christian Medical College. Every week oncology team meets with the surgeons and radiation oncologists to discuss about patient management. There is also a monthly clinico-pathological meetings with the urologists and gynaecologists. Weekly meetings with Palliative Care team are held to allow early involvement of both the teams in patient care, which also ensures continuity of care, by the two teams.
The vision of G. Kuppuswamy Naidu Memorial Hospital to be the foremost health care service provider of the highest standards, focusing on accessible, safe and humane medical services to the community. Established in 1952, it offers a wide range of world class healthcare services at affordable cost to the community. It is a large tertiary, super-specialty hospital with 530 beds. It strives to provide the highest possible standards of medical care and service to the community, and also provides education and training. Valavadi Naryanaswamy Cancer Centre (VNCC) is the specialized Oncology wing of G. Kuppuswamy Naidu Memorial Hospital. It traces its origin to the year 1958 when it was started with a single Deep X-ray therapy unit and Radium needles to treat cancer patients. Over the years the transition from this humble beginning has been phenomenal and it is today regarded as a leading center offering cancer treatment at an affordable cost. VNCC has been recognised by the UICC as a Specialized Cancer Research and Treatment Centre. With over 2000 new cases being registered annually, it remains a leading tertiary referral centre in this part of the country. The first Cobalt unit in Coimbatore was installed in this hospital as early as 1971 followed by a second unit in 1972. A state of the art Linear Accelerator was installed in 2005 with facilities for Intensity Modulated Radiation Therapy (IMRT) - a sophisticated treatment method aimed at delivering radiation precisely to the tumour with minimal side effects on normal tissues. Other facilities include a CT simulator , mould room facility, HDR micro-selectron and computerized treatment planning systems. Excellent surgical expertise has been available at VNCC since inception and has grown and matured considerably with decades of experience in operating on cancer patients. The excellent infrastructure in the form of well equipped operation theatres and efficient paramedical personnel ensure the results are of international quality. Chemotherapy as a specialized treatment is being offered in VNCC for patients with haematological malignancies and solid tumours.
The mission of the Gujarat Cancer Research Institute is to provide state-of-the art diagnostic and therapeutic services to the patients of all types of origin and financial background suffering from cancer. Its scope also encompasses registering the tumor burden in the population, prevention through awareness drives, solving local medical problems through research and training of medical students as well as imparting knowledge to the medical fraternity. To fulfil its mission, Gujarat Cancer Research Institute conducts OPD and indoor activities for diagnosis, staging, treatment and monitoring disease progress; renders free or subsidized treatment to needy patients without any distinction of caste, creed or religion; provides training to new generation of doctors as well as practicing fraternity; offers unique experimental and research-oriented diagnosis and treatment services to test new forms of diagnosis and therapy in order to improve quality of life and expected survival of those afflicted with cancer; organizes public education programmes, the diagnostic and blood donation camps, conferences and other scientific meets; displays a permanent Cancer Awareness and Anti-tobacco exhibition and arranges other preventive efforts; and runs instruction based Hospice Centre, Home-Hospice Services and Rehabilitation Service.
Institute Rotary Cancer Hospital (DR. B.R.A. Institute Rotary Cancer Hospital) started functioning in 1983-84 on 35 beds with infrastructure of 2 floors. Radiodiagnostic and radiotherapy machines including state of art linear accelerator, brachytherapy, stereotactic radiotherapy and intensity modulated radiotherapy are available at this centre. Vaccum assisted advanced mammography unit, first of its kind in India, has made stereotactic breast biopsy possible. Prostate cancer can be diagnosed at an early stage with help of tranrectal sextant biopsy. Radio frequency ablation of liver cancer has also been initiated. DR. B.R.A. Institute Rotary Cancer Hospital is one of the few centres in India to have established hematopoietic stem cell bone marrow transplant programme; more than 250 transplants have been performed. In collaboration with dept. of CTVS, the stem cell transplant programme has been extended to treat myocardial ischemia also. Medical Oncology department have established modern techniques utilizing FISH and polymerase chain reaction (PCR) to prognosticate cancer patients. Innovative research by this department has also demonstrated the liberation of hematopoietic cytokines from fetal liver, with the potential to treat aplastic anemia.
Kidwai Memorial Institute of Oncology - named after the man with a vision for the down trodden and victims of cancer, Mr.Rafi Ahmed Kidwai, the then Governor of Bombay, who donated 20 acres of land and Rs.1.00 lakh for the Radiotherapy machine.This Institute was established on 26th June 1973 with bed strength of 50. The Institute became Autonomous on 8, January 1980. The Government of India has accorded the status of a Regional Cancer Centre on 1, November 1980 to this Institute, thus became one of the 11 Regional Cancer Centres in the country. The Indian Council of Medical Research has recognised this referral Institution as a research association. From the year 1980 to 2001, it has changed the face of the non-descript cancer hospital to a well known major and a model comprehensive regional centre for cancer research and treatment offering sophisticated diagnostic and treatment services to ever increasing numbers of cancer afflicted patients from Karnataka and adjoining areas of Andhra Pradesh, Tamil Nadu, Kerala and Maharashtra. It is next to Tata Memorial Centre in terms of organisation, accommodation, equipment, staff and patient turnover. The Institute with 50 beds at the time of starting has achieved a bed strength of 429. In addition to this, the Bangalore City Corporation Sri Venkateshwara Dharmashala, a unique project of its kind in the country, provides accommodation to about 250 ambulatory cancer patients along with about 250 of their attendants.
Nizam’s Institute of Medical Sciences (NIMS), Hyderabad, is a University established under the Act of Andhra Pradesh State Legislature. NIMS is located at the prime centre of the twin cities of Hyderabad and Secunderabad, and spread over an area of about 23 acres. This Institute extends its services through 27 Departments. Out of them, 14 are Super and Broad Specialties and others are Supporting Departments. The Institute has a bed strength of 946 beds, out of which 603 are in General Wards, 166 in private rooms and 177 in emergency and post operative care. The average number of out-patients visiting the hospital per day is about 1100, and the number of in-patients admitted per day is about 90. The average bed occupancy is over 80%. NIMS has been consistently maintaining a very good patient doctor ratio of about 3:1. The Institute’s focus on research has been strengthened over the years and more than 412 research projects have been completed by various faculty members with the approval of Ethical Committee. In addition about 3000 Research papers were published in national and international journals since 1989. For achieving the above results, NIMS has a fully equipped central research lab and animal research lab. In addition the Institute is recognized by the Department of Science and Technology, Indian council for Medical Research, National Board and Royal College of Radiologists, UK.
Oxford Radcliffe Hospitals is one of the largest NHS teaching trusts in the UK. It provides a wide range of clinical services and medical education, training and research. It has a national and international reputation for the excellence of its services and its role in teaching and research. As a teaching Trust, it has a vital role to play in the education and training of doctors, nurses and other healthcare professionals. It works in close partnership with the University of Oxford and Oxford Brookes University. The Trust is also involved in a wide variety of research programmes, in collaboration with the University of Oxford and many other research bodies. The Trust comprises of the John Radcliffe Hospital in Headington, Oxford; the Chidren’s Hospital and West Wing; the Oxford Heart Centre; The Churchill Hospital, Headington; the Oxford Cancer Centre and the Horton General Hospital, Banbury. The Oxford Radcliffe Hospitals NHS Trust is a base for leading experts in the diagnosis and treatment of cancer and associated conditions. The majority of its services have been brought together on the Churchill site in the new Oxford Cancer Centre.
The Regional Cancer Centre (RCC), Thiruvananthapuram, was established in 1981 by the Government of Kerala and Government of India. We are a comprehensive cancer centre catering to the population of the State of Kerala and the adjoining parts of Tamil Nadu and Karnataka. From a modest beginning, the Regional Cancer Centre has evolved into an internationally recognised centre for conducting a wide range of cancer research and providing state-of-the-art facilities for cancer diagnosis, treatment, palliation and rehabilitation. Medical science at the Regional Cancer Centre focuses on developing and participating in clinical trials (investigational profile) to broaden our knowledge on cancer treatment. Our multidisciplinary staff provide a uniform and coordinated approach to cancer management so that the optimum need of each patient is met. Specialists at the Regional Cancer Centre have International and National recognition in Radiation, Medical and Surgical Oncology, Diagnostic Imaging, Diagnostic Pathology, Pain Management, Oncology Nursing and Social Work. The Regional Cancer Centre carries out a number of National and International clinical trials.
Tata Medical Center (TMC), Kolkata is a philanthropic initiative from the House of Tata. Its mission is to promote Prevention, Early Diagnosis, Treatment, Rehabilitation and Palliation and Research for cancer patients.
This hospital provides the entire spectrum of services from Prevention, Diagnosis, Therapy to Rehabilitation and Palliative support. The Tata Medical Center, Kolkata is a comprehensive Cancer Care Center with well-trained professional staff and equipped with modern facilities and the most contemporary medical equipment.
The Hospital, with a capacity of 167 beds serves all sections of the Society, with 50% earmarked for free or subsidized treatment for the underprivileged sections of society. The Institution's objective is to excel in service, education and research.
The Tata Memorial Centre is the national comprehensive cancer centre for the prevention, treatment, education and research in Cancer and is recognised as one of the leading cancer centres in this part of the world. This achievement has been possible due to the far-sighted and total support of the Department of Atomic Energy, responsible for managing this Institution since 1962 . The Tata Memorial Hospital was initially commissioned by the Sir Dorabji Tata Trust on 28 February 1941 as a center with enduring value and a mission for concern for the Indian people. In 1952 the Indian Cancer Research Centre was established as a pioneer research institute for basic research - later called the Cancer Research Institute (CRI). In 1957 the Ministry of Health took over the Tata Memorial Hospital. The transfer of the administrative control of the Tata Memorial Centre (Tata Memorial Hospital & Cancer Research Institute) to the Department of Atomic Energy in 1962 was the next major milestone. The Tata Memorial Hospital and Cancer Research Institute merged as the two arms of the Tata Memorial Centre (TMC) in 1966 as a classic example of private philanthropy augmented by Government support with a mandate for Service, Education & Research in Cancer.